FETAL EFFECTS OF STEROID THERAPY DURING PREGNANCY.
D000014:Abnormalities, Drug-Induced; D009008:Abnormalities, Severe Teratoid; D002987:Clitoris; D004054:Diethylstilbestrol; D012734:Disorders of Sex Development; D004966:Estrogens, Conjugated (USP); D004997:Ethinyl Estradiol; D005260:Female; D005315:Fetal Diseases; D005333:Fetus; D006801:Humans; D006908:Hydroxyprogesterones; D008431:Maternal-Fetal Exchange; D009640:Norethindrone; D009641:Norethynodrel; D011247:Pregnancy; D011374:Progesterone; D014116:Toxicology
D004966:Estrogens, Conjugated (USP); D006908:Hydroxyprogesterones; D004997:Ethinyl Estradiol; D011374:Progesterone; D004054:Diethylstilbestrol; D009641:Norethynodrel; D009640:Norethindrone
ABNORMALITIES, DRUG-INDUCED; CLITORIS; DIETHYLSTILBESTROL; ESTROGENIC SUBSTANCES, CONJUGATED; ETHINYL ESTRADIOL; FETAL DISEASES; HERMAPHRODITISM; HYDROXYPROGESTERONE; MATERNAL-FETAL EXCHANGE; MONSTERS; NORETHINDRONE; NORETHYNODREL; PREGNANCY; PROGESTERONE; SEX DIFFERENTIATION DISORDERS; TOXICOLOGIC REPORT